Suppressed but Still at Risk: HIV-Related Complications
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Immunology".
Deadline for manuscript submissions: closed (15 February 2024) | Viewed by 4723
Special Issue Editor
Special Issue Information
Dear Colleagues,
Infection with the human immunodeficiency virus (HIV) causes a progressive, multifactorial impairment of the immune system associated with deleterious immune-related infectious and non-infectious adverse sequelae even after successful viral load suppression. One of the major infections associated with the altered immune response in people living with HIV is tuberculosis, and they continue to be at great risk even while on antiretrovirals. Additionally, HIV-related chronic inflammation, which cannot be completely controlled with antiretrovirals, is associated with multiple non-infectious comorbidities, including but not limited to increased cardiovascular risk, osteoporosis, gonadal dysfunction, cognitive impairment, and malignancies.
Therefore, this Special Issue will summarize the immune-related complications of people living with HIV while on antiretrovirals in the modern era.
We look forward to your contributions.
You may choose our Joint Special Issue in JCM.
Dr. Styliani Karanika
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HIV
- TB
- cardiovascular risk
- non-AIDS metabolic comorbidities
- HIV and aging
- T cells
- dendritic cells
- antiretrovirals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.